Fan CY, Jiang J, Zeng BF, Jiang PZ, Cai PH, Chung KC Reconstruction of thumb loss complicated by skin defects in the thumb-index web space by combined transplantation of free tissues. J Hand Surg Am. 2006 Feb;31(2):236-41.
Hill J, Bird HA, Lawton CW, Wright V The arthritis impact measurement scales: an anglicized version to assess the outcome of British patients with rheumatoid arthritis. Br J Rheumatol. 1990 Jun;29(3):193-6.
Li L, Wang H, Shen Y Development and psychometric tests of a Chinese version of the SF-36 Health Survey Scales. Zhonghua Yu Fang Yi Xue Za Zhi. 2002 Mar;36(2):109-13.
Wan C, Zhang D, Yang Z, Tu X, Tang W, Feng C, Wang H, Tang X Validation of the simplified Chinese version of the FACT-B for measuring quality of life for patients with breast cancer. Breast Cancer Res Treat. 2007 Dec;106(3):413-8. Epub 2007 Mar 22.
Wang XS, Mendoza TR, Gao SZ, Cleeland CS The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain. 1996 Oct;67(2-3):407-16.
Xie F, Li SC, Lo NN, Yeo SJ, Yang KY, Yeo W, Chong HC, Fong KY, Thumboo J Cross-cultural adaptation and validation of Singapore English and Chinese Versions of the Oxford Knee Score (OKS) in knee osteoarthritis patients undergoing total knee replacement. Osteoarthritis Cartilage. 2007 Sep;15(9):1019-24. Epub 2007 Apr 3.
Zhu, J , Zhang, Y., Pang, L., & Fu, H. (2006) Test of Reliability and Validity of Short-Form Arthritis Impact Measurement Scales2 (AIMS2-SF). Chinese Journal of Prevention and Control of Chronic Non- Communicable Diseases, 14: 7577.
Acupuncture for Joint Symptoms in Patients With Breast Cancer: A Randomised Controlled Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.